Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 1.000 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.786 | |
| 4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.700 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.636 | |
| 2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.553 | |
| 2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.534 | |
| 4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.520 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.512 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.510 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.489 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.484 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.479 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.479 | |
| 2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.478 | |
| 2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.478 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.477 | |
| 1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
| 4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.472 | |
| 2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.469 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.469 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.468 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.468 | |
| 4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.468 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.468 | |
| 4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.467 | |
| 2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.466 | |
| 3bc3 | OPT | Cathepsin L1 | 3.4.22.15 | 0.465 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.465 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.465 | |
| 2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.464 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.463 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.463 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.462 | |
| 1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.462 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.462 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.461 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.459 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.459 | |
| 2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.458 | |
| 5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.456 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.456 | |
| 3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.455 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.455 | |
| 4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
| 1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.452 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.451 | |
| 4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.451 | |
| 4qgi | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.450 | |
| 2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 2q54 | MU1 | Protease | / | 0.450 | |
| 2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.450 | |
| 3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.450 | |
| 4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.450 | |
| 1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.449 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.449 | |
| 3il1 | B5D | Glutamate receptor 2 | / | 0.449 | |
| 1idb | 0DO | Gag-Pol polyprotein | / | 0.448 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.448 | |
| 3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 1q1w | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.447 | |
| 2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
| 3c50 | ADP | Rhodopsin kinase | / | 0.447 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.447 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.447 | |
| 4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.447 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.447 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.446 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
| 4hdf | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
| 4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
| 1me7 | MOA | Inosine-5'-monophosphate dehydrogenase | / | 0.445 | |
| 2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
| 2wtj | WTJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 2yyi | FAD | 4-hydroxyphenylacetate 3-monooxygenase oxygenase component | 1.14.14.9 | 0.445 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.445 | |
| 1a8g | 2Z4 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 1j39 | UPG | DNA beta-glucosyltransferase | / | 0.444 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.444 | |
| 2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.444 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.444 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.444 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.444 | |
| 2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
| 3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.443 | |
| 1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.442 | |
| 1hvs | A77 | Gag-Pol polyprotein | / | 0.442 | |
| 1ndz | FR5 | Adenosine deaminase | 3.5.4.4 | 0.442 | |
| 1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 1rfu | ADP | Pyridoxal kinase | 2.7.1.35 | 0.442 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
| 3ekp | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.442 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.442 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.441 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.441 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.441 | |
| 3o9i | A61 | Gag-Pol polyprotein | / | 0.441 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.441 | |
| 4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.441 | |
| 4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.441 | |
| 2hw1 | ANP | Ketohexokinase | / | 0.440 | |
| 2pzi | AXX | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.440 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
| 3qa2 | XNA | Ketohexokinase | / | 0.440 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.440 |